Wolters Kluwer

18/06/26 -"We have slightly cut our DCF-derived target price after the publication of a study in Nature Medicine (https://www.nature.com/articles/s41591-026-04431-5) suggesting that clinical decision support ..."

PDF page sample
Pages
60
Language
English
Published on
18/06/26
Download
You may also be interested by these reports :
16/07/26
Publicis delivered strong organic net revenue growth in Q2 2026, driven by Connected Media and Intelligent Creativity, which represent 87% of net ...
06/07/26
Our opinion is changing from Sell to Reduce as a result of a slightly higher DCF valuation, confirming our previous feeling that the price set for ...
06/07/26
ITV has officialised the sale of its Media & Entertainment unit to Sky for £1.6bn, confirming the elements unveiled by Reuters two weeks ago. ITV ...
18/06/26
We have slightly cut our DCF-derived target price after the publication of a study in Nature Medicine ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO